Early Continence Recovery after Preservation of Maximal Urethral Length until the Level of Verumontanum during Radical Prostatectomy: Primary Oncological and Functional Outcomes after 1 Year of Follow-Up
Table 2
Clinical and pathological findings regarding the preservation of urethra until the level of verumontanum.
Group A
Group B
Number of patients
115
129
Age (years), mean ± std, IQR
66.8 ± 6.68, 9
65.6 ± 6.28, 8
0.058†
PSA (ng/mL), mean ± std, IQR
9.15 ± 4.15, 5.7
9.43 ± 5.82, 4.83
0.562†
Preoperative Gleason score, (%)
0.969‡
≤6
57 (49.6)
66 (51.2)
7
45 (39.1)
49 (38.0)
≥8
13 (11.3)
14 (10.9)
Pathological Gleason score, (%)
0.871‡
≤6
45 (39.1)
49 (38.0)
7
50 (43.5)
60 (46.5)
≥8
20 (17.4)
20 (15.5)
Pathological stage, (%)
0.433‡
T2a
12 (10.4)
16 (12.4)
T2b
4 (3.48)
5 (3.88)
T2c
63 (54.8)
77 (59.7)
T3a
18 (15.7)
21 (16.3)
T3b
18 (15.7)
10 (7.75)
Extracapsular disease, (%)
0.204‡
Yes
36 (31.3)
31 (24.0)
No
79 (68.7)
98 (76.0)
Surgical margins, (%)
0.562‡
Negative
96 (83.5)
104 (80.6)
Positive
19 (16.5)
25 (19.4)
Biochemical relapse, (%)
0.321‡
Yes
20 (17.4)
19 (14.7)
No
95 (82.6)
110 (85.3)
Urgency at 1st month, (%)
<0.001‡*
Yes
71 (61.7)
45 (34.9)
No
44 (38.3)
84 (65.1)
Nocturia at 1st month, (%)
<0.001‡*
Yes
74 (64.3)
47 (36.4)
No
41 (35.7)
82 (63.6)
Incontinence at 1st month, (%)
Urge
29 (25.2)
18 (14.0)
0.026‡*
Stress
62 (53.9)
53 (41.1)
0.045‡*
Incontinence at 1st year, (%)
Urge
12 (10.4)
11 (8.53)
0.611‡
Stress
24 (20.9)
23 (17.8)
0.548‡
Pads/day, mean ± std, IQR
1 month
1.27 ± 0.91, 1
1.02 ± 0.81, 1
0.037†*
3 months
0.58 ± 0.74, 1
0.34 ± 0.63, 1
0.003†*
6 months
0.34 ± 0.62, 1
0.18 ± 0.44, 0
0.032†*
12 months
0.11 ± 0.44, 0
0.06 ± 0.27, 0
0.579†
ICIQ-SF, mean ± std, IQR
1 month
7.54 ± 5.42, 9
5.13 ± 4.39, 8
0.001†*
3 months
4.97 ± 6.08, 11
1.96 ± 3.96, 0
<0.001†*
6 months
2.44 ± 4.63, 3
1.23 ± 3.20, 0
0.021†*
12 months
2.57 ± 5.54, 0
0.92 ± 3.31, 0
0.11†
IIQ-SF, mean ± std, IQR
1 month
5.99 ± 4.97, 9
4.46 ± 4.22, 8
0.021†*
3 months
3.48 ± 4.36, 7
1.35 ± 2.70, 0
<0.001†*
6 months
1.56 ± 3.34, 0
0.81 ± 2.51, 0
0.057†
12 months
0.63 ± 2.56, 0
0.38 ± 1.62, 0
0.590†
Mann-Whitney test, ‡Chi-square test, *statistically significant, std: standard deviation, IQR: interquartile range, ICIQ-SF: international consultation on incontinence questionnaire-short form, and IIQ-SF: incontinence impact questionnaire-short form.
